Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLASMA 2: A-002 in Stable Coronary Artery Disease
NCT00525954Phase 2Completed
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- Sep 2007
- Countries
- 1
01
Overview
A Phase 2 trial of varespladib methyl in coronary artery disease (CAD), sponsored by Anthera Pharmaceuticals, Inc.. Started Sep 2007; status: completed.
02
Drugs
varespladib methyl
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00525954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525954.